Home
About
Overview
Sharing Data
ORCID
Help
History (19)
P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
Minimum energy trajectories of the swing ankle when stepping over obstacles of different heights.
Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors.
Treatment of perianal Crohn's disease: a medical approach.
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease.
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease. Expert Rev Clin Immunol. 2023 Jul-Dec; 19(9):1075-1089.
View in:
PubMed
subject areas
Adult
Colitis, Ulcerative
Crohn Disease
Europe
Humans
Inflammatory Bowel Diseases
Janus Kinase Inhibitors
authors with profiles
Stephen B. Hanauer